Overview

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of two strengths of HY02 Ointment versus Vehicle administered twice daily for twelve weeks in subjects with a diagnosis of Inflamed Meibomian Gland Dysfunction.
Phase:
Phase 2
Details
Lead Sponsor:
Hovione Scientia Limited
Treatments:
Minocycline